Helus Pharma Inc. recorded one notable insider transaction during the past ninety days. Senior officer Aaron Frank Bartlone executed a sale of 51,184 shares, totaling approximately 539,362 USD on October 19, 2026. This divestment represents the sole reported activity, occurring outside the immediate window of any recent quarterly earnings report.